Main Article Content
severe asthma, paediatric, epidemiology, premature, tobacco, heavy traffic, adherence
Introduction and objectives: Relationship between the causal mechanisms of pediatric severe asthma and severity of symptoms would be helpful for developing personalized strategies for treatment and prevention.
Materials and methods: For this study, 698 medical histories of asthmatics between 6 and 18 years of age were reviewed in a period of 2 years. Variables analyzed were: age, sex, ethnicity, perinatological history, allergy history, asthma predictive index (API), exposure to tobacco, heavy traffic or epithelium, lung function, age of onset of symptoms, hospitalization admissions/PICU, systemic corticosteroids, daily symptoms control, device prescribe for daily control, and adherence.
Results: A total of 86 children with severe asthma were included (12.3%). Mean age 13.3 +/− 1.86 years, sex ratio1:1, mean age of symptom onset 2.765 +/− 3.06 years, mean IgE 1076.18KU / L +/− 1136, mean eosinophils 604c / mcl +/− 511.9, mean of FEV1 93.15% +/− 16.3. Evidently, 70 children (81.4%) had positive API, 68 (79.1%) rhinitis, 34 (39.5%) atopic dermatitis. 73 (83.9%) sensitized to inhalants and 56 (65.1%) to dermatophagoides, 39 (45.3%) passive smokers, 19 (22.1%) exposure to heavy traffic; 55 (64%) showed symptoms with exercise, 35 (40.7%) had audible wheezing. The mean systemic corticosteroid cycles/year was 3.63 +/− 3.23, mean PICU admissions 0.36 +/− 0.83, mean hospital admissions 4.31 +/− 5.3, average emergency room visits/year 19.44 +/− 16.28. 38 (56.7%) had good adherence, 44 (51%) used an MDI device and 39 (45.3%) used dry powder.
Conclusions: Children with severe asthma meet the following criteria: premature, positive API, rhinitis, atopic dermatitis, high IgE, eosinophilia, passive smokers, exposure to heavy traffic, decreased lung function, and low adherence to controller medication.
2. Helen K. Reddel, D. Robin Taylor, et al. American Thoracic Society Documents. AN official American Thoracic Society/ European Respiratory Society Statement: Asthma Control and Exacerbations, 2009. Am J Respir Crit Care Med Vol 180. pp 59–99.
3. Teague WG, Phillips BR, Fahy JV, et al. Baseline features of the Severe Asthma Research Program (SARP III) Cohort: Differences with age, 2018. J Allergy Clin Inmunol Pract. Mar-Apr; 6(2): 545–554 e4. https://doi.org/10.1016/j. jaip.2017.05.032
4. Ferreira de Magalhäes M, Amaral R, Pererira AM, et al. Cost of asthma in children: a nationwide, population-based, cost-of-illness study, 2017. Pediatr Allergy Immunol. Nov; 28(7), 683–691. https://doi.org/10.1111/pai.12772
5. Belgrave D, Henderson J, et al. Disaggregating asthma: Big investigation versus big data. J Allergy Clin Immunol. 2017 feb; 139(2): 400–407. https://doi.org/10.1016/j.jaci.2016.11. 003
6. Berry A, Busse W.W. Biomarkers in asthmatic patients: has their time come to direct treatment? J Allergy Clin Inmunol. 2016;137:1317–1324. https://doi.org/10.1016/j.jaci.2016.03. 009
7. Fitzpatrick AM. Severe Asthma in children: lessons learned and future directions. J Allergy Clin Immunol Pract. 2016; 4(1): 11–19. https://doi.org/10.1016/j.jaip.2015.10.008
8. Rosas-Salazar C, et al. Prematurity, atopy, and childhood asthma in Puerto Ricans. J Allergy Clin Immunol. 2014; 133(2):357–362. [PubMed: 24139607] https://doi.org/10.1016/j. jaci.2013.09.003
9. Shah S, Yeung C, Spentzas T. Impact of environmental tobacco smoke on children admitted with status smathicus in the pediatric intensive care unit; Pediatr Pulmonol. 2011 Mar;46(3):224–229. https://doi.org/10.1002/ppul.21355
10. Kobayashi Y, Bossley C, Gupta A, et al. Passive smoking impairs histone deacetylase-2 in children with severe asthma. Chest. 2014; 145(2):305–312. https://doi.org/10.1378/chest.13-0835
11. Eun Lee et al. Associated Factors for Asthma Severity in Korean Children: A Korean Childhood Asthma Study, 2020. Allergy Asthma Immunol Res. 2020 Jan;12(1):86–98. https:// doi.org/10.4168/aair.2020.12.1.86
12. Robert F Lemanske. Issues in understanding pediatric asthma: epidemiology and genetics, 2002. J Allergy clin Inmunol; 109:S521–S524. https://doi.org/10.1067/mai.2002.124564
13. Lang A, Carlsen KH, et al. Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy. 2008; 63: 1054– 1060. https://doi.org/10.1111/j.1398-9995.2008.01672.x
14. Kristie R. Ross, MD,a Ritika Gupta. Severe asthma during childhood and adolescence: A longitudinal study. J Allergy Clin Inmunol; 145 (1).
15. Chung KF, Wenzel SE, et al. International ERS/ATS Consensus Definition, Mechanisms, Evaluation and Treatment of Severe Asthma. Eur Respir J. 2014; 43(2): 343–373. [PubMed: 24337046] https://doi: 10.1183/09031936.00202013
16. Alobid I, Álvarez Rodríguez C, et al. Guía Española para el Manejo del Asma GEMA 5.0, 2020. 1.5:31.